{"DataElement":{"publicId":"3287320","version":"1","preferredName":"Stage Prognostic Factor Derived Neoadjuvant Therapy Code","preferredDefinition":"This field indicates whether the patient received neoadjuvant therapy (systemic therapy or radiation therapy prior to first course surgical treatment) as part of first course of treatment.","longName":"3287300v1.0:3287310v1.0","context":"PS-CC","contextVersion":"1","DataElementConcept":{"publicId":"3287300","version":"1","preferredName":"Stage Prognostic Factor Derived Neoadjuvant Therapy","preferredDefinition":"The extent of a cancer in the body._Having value for making predictions._An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process._The source from which something comes or issues; to take, obtain, or receive from a source._Treatment designed to be used as a first step toward shrinking the cancer and in evaluating response to drugs and other agents. Induction therapy is followed by additional therapy to eliminate whatever cancer remains.","longName":"2688190v1.0:3287298v1.0","context":"PS-CC","contextVersion":"1","ObjectClass":{"publicId":"2688190","version":"1","preferredName":"Stage Prognostic Factor","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.:The general personal and health characteristics that have a bearing on the course of a disease and its eventual outcome.","longName":"C16899:C18959","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Prognostic Factor","conceptCode":"C18959","definition":"The general personal and health characteristics that have a bearing on the course of a disease and its eventual outcome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3C0FC8A1-D62E-5124-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-09","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-10-09","modifiedBy":"ONEDATA","dateModified":"2007-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3287298","version":"1","preferredName":"Derived Neoadjuvant Therapy","preferredDefinition":"To take, obtain, or receive from a source; having been determined by mathematical computation. :Treatment designed to be used as a first step toward shrinking the cancer and in evaluating response to drugs and other agents. Induction therapy is followed by additional therapy to eliminate whatever cancer remains.","longName":"C42885:C15665","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Derivation","conceptCode":"C42885","definition":"The source from which something comes or issues; to take, obtain, or receive from a source.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoadjuvant Therapy","conceptCode":"C15665","definition":"Therapy administered prior to the primary treatment for the purpose of making the primary treatment more effective.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE067832-F31B-A196-E040-BB89AD436B62","latestVersionIndicator":"Yes","beginDate":"2011-09-28","endDate":null,"createdBy":"CURTIST","dateCreated":"2011-09-28","modifiedBy":"ONEDATA","dateModified":"2011-09-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NAACCR:North American Association of Central Cancer Registries","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE067832-F32C-A196-E040-BB89AD436B62","latestVersionIndicator":"Yes","beginDate":"2010-06-15","endDate":null,"createdBy":"CURTIST","dateCreated":"2011-09-28","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3287310","version":"1","preferredName":"Derived Neoadjuvant Therapy Code","preferredDefinition":"To take, obtain, or receive from a source; having been determined by mathematical computation._Treatment designed to be used as a first step toward shrinking the cancer and in evaluating response to drugs and other agents. Induction therapy is followed by additional therapy to eliminate whatever cancer remains._._A system of numbered categories for representation of data.","longName":"3287310v1.0","context":"PS-CC","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"9","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE06A336-6719-4F1B-E040-BB89AD431197","beginDate":"2011-09-28","endDate":null,"createdBy":"CURTIST","dateCreated":"2011-09-28","modifiedBy":"ONEDATA","dateModified":"2011-09-28","deletedIndicator":"No"},{"value":"1","valueDescription":"Neoadjuvant therapy was administered as part of the first course of therapy","ValueMeaning":{"publicId":"3287311","version":"1","preferredName":"Neoadjuvant therapy was administered as part of the first course of therapy","longName":"3287311","preferredDefinition":"Neoadjuvant therapy was administered as part of the first course of therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE06A336-6723-4F1B-E040-BB89AD431197","latestVersionIndicator":"Yes","beginDate":"2011-09-28","endDate":null,"createdBy":"CURTIST","dateCreated":"2011-09-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE06A336-673C-4F1B-E040-BB89AD431197","beginDate":"2011-09-28","endDate":null,"createdBy":"CURTIST","dateCreated":"2011-09-28","modifiedBy":"ONEDATA","dateModified":"2011-09-28","deletedIndicator":"No"},{"value":"0","valueDescription":"Neoadjuvant therapy was not administered as part of the first course of therapy","ValueMeaning":{"publicId":"3287312","version":"1","preferredName":"Neoadjuvant therapy was not administered as part of the first course of therapy","longName":"3287312","preferredDefinition":"Neoadjuvant therapy was not administered as part of the first course of therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE06A336-6746-4F1B-E040-BB89AD431197","latestVersionIndicator":"Yes","beginDate":"2011-09-28","endDate":null,"createdBy":"CURTIST","dateCreated":"2011-09-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE06A336-675F-4F1B-E040-BB89AD431197","beginDate":"2011-09-28","endDate":null,"createdBy":"CURTIST","dateCreated":"2011-09-28","modifiedBy":"ONEDATA","dateModified":"2011-09-28","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435030","version":"1","preferredName":"NCI Administrative Concept","preferredDefinition":"Conceptual entities required by NCI operations and systems. Includes administrative, financial, organizational and quasi-scientific concepts required for NCI operations and systems. ","longName":"C28389","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07432182-1611-25E9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3287309","version":"1","preferredName":"Derived Neoadjuvant Therapy Code","preferredDefinition":"To take, obtain, or receive from a source; having been determined by mathematical computation. :Treatment designed to be used as a first step toward shrinking the cancer and in evaluating response to drugs and other agents. Induction therapy is followed by additional therapy to eliminate whatever cancer remains.:A system of numbered categories for representation of data.","longName":"C42885:C15665:C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Derivation","conceptCode":"C42885","definition":"The source from which something comes or issues; to take, obtain, or receive from a source.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Neoadjuvant Therapy","conceptCode":"C15665","definition":"Therapy administered prior to the primary treatment for the purpose of making the primary treatment more effective.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE06A336-66F1-4F1B-E040-BB89AD431197","latestVersionIndicator":"Yes","beginDate":"2011-09-28","endDate":null,"createdBy":"CURTIST","dateCreated":"2011-09-28","modifiedBy":"ONEDATA","dateModified":"2011-09-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NAACCR:North American Association of Central Cancer Registries","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE06A336-6702-4F1B-E040-BB89AD431197","latestVersionIndicator":"Yes","beginDate":"2010-06-15","endDate":null,"createdBy":"CURTIST","dateCreated":"2011-09-28","modifiedBy":"CURTIST","dateModified":"2011-12-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2193114","version":"1","longName":"Division of Cancer Control and Population Sciences","context":"PS-CC","ClassificationSchemeItems":[{"publicId":"3134707","version":"1","longName":"NAACCR 12.1","context":"PS-CC"},{"publicId":"5899845","version":"1","longName":"StageProgFactors16","context":"PS-CC"},{"publicId":"5899833","version":"1","longName":"NAACCR 16","context":"PS-CC"},{"publicId":"7464305","version":"1","longName":"NAACCR 18","context":"PS-CC"},{"publicId":"7464319","version":"1","longName":"StageProgFactors18","context":"PS-CC"}]}],"AlternateNames":[{"name":"3600","type":"NAACCR Item #","context":"PS-CC"},{"name":"DERIVED NEOADJUV RX FLAG","type":"NAACCR Item Name","context":"PS-CC"},{"name":"Derived Neoadjuv Rx Flag","type":"NAACCR Item Name","context":"PS-CC"}],"ReferenceDocuments":[{"name":"Derived Neoadjuvant Treatment","type":"Preferred Question Text","description":"Derived Neoadjuvant Treatment Flag","url":null,"context":"PS-CC"},{"name":"NAACCR 12.1, Data Stds/Dict.","type":"REFERENCE","description":"For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 12.1 Data Standards and Data Dictionary (6/2010)","url":"http://www.naaccr.org/LinkClick.aspx?fileticket=LJJNRVo4lT4%3d&tabid=133&mid=473","context":"PS-CC"},{"name":"Neoadjuvant Therapy Coding Information","type":"Coding Instructions","description":"See the most current version of the Collaborative Stage Data Collection System (http://cancerstaging.org/cstage/manuals.html), for rules and site-specific codes and coding structures.","url":null,"context":"PS-CC"},{"name":"NAACCR 16, Data Stds/Dict.","type":"REFERENCE","description":"For additional details see NAACCR, Standards for Cancer Registries Volume II, Version 16 Data Standards and Data Dictionary (01/2016)","url":"https://www.naaccr.org/data-standards-data-dictionary/","context":"PS-CC"}],"origin":"NAACCR:North American Association of Central Cancer Registries","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE06A336-6795-4F1B-E040-BB89AD431197","latestVersionIndicator":"Yes","beginDate":"2010-06-15","endDate":null,"createdBy":"CURTIST","dateCreated":"2011-09-28","modifiedBy":"HARTLEYG","dateModified":"2018-11-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}